PharmExec Direct: Having trouble viewing the email? Click Here

In this ISSUE

Design that Delivers

Tricky Path to Risk-Sharing Agreements

Promises and Pitfalls in Calculating Drug Value
Opinion
Pharm Exec's Top 50 Companies 2016
Pharm Exec's 16th annual listing of the top biopharma players points to important transitions taking place in the larger business model.
... /Read more/
Advertisement
Watch this brief video to learn how analytics can help your product access program.
Learn more
Regulatory Affairs
California and the Future of the US Rx Pricing
California is in the process of potentially establishing a new, disruptive healthcare policy that is proving to be very concerning to the American Rx industry, writes Tom Norton.
... /Read more/
Calendar
/ Off-Label Guidelines /
 
/ Publication & Clinical Trial Disclosure /
 
Opinion
Diversity and Inclusion: A Pharma 50 Perspective
Biopharma's diversity commitment remains a work in progress but the benefits—in measurable ROI—are increasingly clear.
... /Read more/
Technology
A Digital Prescription for the Pharma Industry
How companies can better integrate valuable data across business functions to meet rising value-chain demands.
... /Read more/
Technology
Cancer's Disruptive Dozen
The World Medical Innovation Forum presents its second list of breakthrough technologies—this time focused on oncology.
... /Read more/

update my profile / advertise with us / print & digital subscribe / visit pharmexec.com